article thumbnail

Edwards Lifesciences to Sell Critical Care to BD

DAIC

Getty Images milla1cf Wed, 06/05/2024 - 20:33 June 5, 2024 — Edwards Lifesciences announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company), in an all-cash transaction valued at $4.2

article thumbnail

Edwards Acquires JenaValve and Endotronix, Expands into Aortic Regurgitation and Heart Failure

CardiacWire

Edwards Lifesciences is going all-in on structural heart and heart failure, acquiring aortic valve-maker JenaValve Technology and implantable heart failure monitor company Endotronix for $1.2B and up to $445M in milestone payments.

article thumbnail

Predicting mortality in heart failure: BUN/creatinine ratio in MIMIC-III

Frontiers in Cardiovascular Medicine

AimsHeart failure is a critical health issue with high mortality rates. The blood urea nitrogen/creatinine ratio (BCR) has proven more effective at predicting outcomes in heart failure patients than individual assessments of each marker. there was no significant correlation with long-term mortality; between 12.5

article thumbnail

Blood Speckle Imaging in Critical Care: A New Tool in Mechanical Circulatory Support Management

Circulation: Heart Failure

Circulation: Heart Failure, Ahead of Print.

article thumbnail

Leveraging AI-Enabled Remote Cardiac Monitoring to Improve Cardiovascular Care

DAIC

As a result, healthcare faces rising expenses from frequent emergency room visits, lengthy hospital stays, costly procedures like stent placements and bypass surgeries, as well as the long-term management of chronic conditions like heart failure (HF). In fact, approximately1 in 8 health care dollarsis spent on cardiovascular disease.

article thumbnail

Revolutionary Genomic Study Sheds Light on Immune Microenvironment in Transplanted Pediatric Hearts

DAIC

THE TEXAS HEART INSTITUTE 2024 milla1cf Tue, 02/13/2024 - 17:56 February 13, 2024 — Pediatric heart transplantation has long been hailed as a life-saving intervention for children suffering from end-stage heart failure.

article thumbnail

AISAP’s CARDIO AI-powered Diagnostic Assessment Software Receives FDA Clearance

DAIC

“AISAP CARDIO has the potential to be a game-changer in the world of point-of-care ultrasound,” said Smadar Kort, MD, system director of Non Invasive Cardiac Imaging, Stony Brook Medicine, and past governor of the American College of Cardiology. “We